Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 11/20 | 0.73 |
| ▸ | SRD5A2 | P31213 | 8/20 | 0.73 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.54 |
| ▸ | FNTA | P49354 | 2/20 | 0.52 |
| ▸ | FNTB | P49356 | 2/20 | 0.52 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8965032 | 0.85 | SRD5A1 (1.00) | SRD5A1SRD5A2CYP2D6CYP2C19FNTA | |
| SCHEMBL8965030 | 0.85 | SRD5A1 (1.00) | SRD5A1SRD5A2CYP2D6CYP2C19FNTA | |
| SCHEMBL17817402 | 0.85 | SRD5A1 (1.00) | SRD5A1SRD5A2CYP2D6CYP2C19FNTA | |
| SCHEMBL9393855 | 0.84 | SRD5A1 (0.52) | SRD5A1SRD5A2CYP2D6CYP2C19 | |
| SCHEMBL4448191 | 0.81 | SRD5A1 (0.72) | SRD5A1SRD5A2CYP2D6CYP2C19INPP5D | |
| SCHEMBL4457359 | 0.80 | SRD5A1 (0.69) | SRD5A1SRD5A2CYP2D6CYP2C19INPP5D | |
| SCHEMBL4636872 | 0.80 | SRD5A1 (0.69) | SRD5A1SRD5A2CYP2D6CYP2C19INPP5D | |
| SCHEMBL1290265 | 0.80 | SRD5A1 (0.73) | SRD5A1SRD5A2CYP2D6CYP2C19INPP5D | |
| SCHEMBL4636223 | 0.79 | SRD5A1 (0.68) | SRD5A1SRD5A2CYP2D6CYP2C19INPP5D | |
| SCHEMBL4448192 | 0.79 | SRD5A1 (0.71) | SRD5A1SRD5A2CYP2D6CYP2C19INPP5D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008079898-A1 | METHODS AND TOPICAL FORMULATIONS COMPRISING COLLOIDAL METAL FOR TREATING OR PREVENTING SKIN CONDITIONS | PHARMWEST, INC. (US) | 2008-07-03 | — | — | WO | claimed |
| EP-0833641-A4 | TREATMENT AND PREVENTION OF PROSTATIC DISEASE | MERCK & CO INC (US) | 2000-04-05 | — | — | EP | claimed |
| US-5872126-A | ENZYME INHIBITORS FOR TREATMENT OF PREMATURE LABOR | MERCK & CO., INC. (US) | 1999-02-16 | — | — | US | claimed |
| EP-0833641-A1 | TREATMENT AND PREVENTION OF PROSTATIC DISEASE | Merck & Co., Inc. (US) | 1998-04-08 | — | — | EP | claimed |
| WO-1998009632-A1 | METHODS AND COMPOSITIONS FOR TREATING PRETERM LABOR | MERCK & CO., INC. (US) | 1998-03-12 | — | — | WO | claimed |
| EP-0788483-A4 | 7-SUBSTITUTED 4-AZA CHOLANIC ACID DERIVATIVES AND THEIR USE | MERCK & CO INC (US) | 1997-12-10 | — | — | EP | claimed |
| EP-0788483-A1 | 7-SUBSTITUTED 4-AZA CHOLANIC ACID DERIVATIVES AND THEIR USE | Merck & Co., Inc. (US) | 1997-08-13 | — | — | EP | claimed |
| WO-1996040150-A1 | TREATMENT AND PREVENTION OF PROSTATIC DISEASE | MERCK & CO., INC. (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996012705-A1 | 7-SUBSTITUTED 4-AZA CHOLANIC ACID DERIVATIVES AND THEIR USE | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-2624806-A2 | COSMETIC SKIN CARE COMPOSITIONS COMPRISING INSOLUBLE COPPER OXIDE | Cupron Inc. (US) | 2013-08-14 | — | — | EP | disclosed |
| WO-2012046229-A2 | COSMETIC SKIN CARE COMPOSITIONS | CUPRON SCIENTIFIC LTD (IL) | 2012-04-12 | — | — | WO | disclosed |
| WO-2011051948-A2 | HAIR CARE COMPOSITIONS AND MATERIALS | CUPRON SCIENTIFIC LTD (IL) | 2011-05-05 | — | — | WO | disclosed |
| WO-2008079898-A1 | METHODS AND TOPICAL FORMULATIONS COMPRISING COLLOIDAL METAL FOR TREATING OR PREVENTING SKIN CONDITIONS | PHARMWEST, INC. (US) | 2008-07-03 | — | — | WO | disclosed |
| EP-1171126-A4 | 6-AZAINDOLE COMPOUNDS AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | MERCK & CO INC (US) | 2002-03-27 | — | — | EP | disclosed |
| WO-1999051233-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | MERCK & CO., INC. (US) | 1999-10-14 | — | — | WO | disclosed |
| WO-1998055479-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | MERCK & CO., INC. (US) | 1998-12-10 | — | — | WO | disclosed |
| EP-0788483-A4 | 7-SUBSTITUTED 4-AZA CHOLANIC ACID DERIVATIVES AND THEIR USE | MERCK & CO INC (US) | 1997-12-10 | — | — | EP | disclosed |
| EP-0788483-A1 | 7-SUBSTITUTED 4-AZA CHOLANIC ACID DERIVATIVES AND THEIR USE | Merck & Co., Inc. (US) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996012705-A1 | 7-SUBSTITUTED 4-AZA CHOLANIC ACID DERIVATIVES AND THEIR USE | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | disclosed |
| WO-1996007643-A1 | PROCESS FOR THE STEREOSELECTIVE REDUCTION OF STEROID ENELACTAMS | MERCK & CO., INC. (US) | 1996-03-14 | — | — | WO | disclosed |